The Board of Directors of Suzhou Fushilai Pharmaceutical Co., Ltd. has authorized a buyback plan on February 5, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
28.14 CNY | +20.00% | +25.40% | -12.83% |
1st Jan change | Capi. | |
---|---|---|
-12.83% | 356M | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
+8.08% | 167B | |
-3.40% | 157B |
- Stock Market
- Equities
- 301258 Stock
- News Suzhou Fushilai Pharmaceutical Co., Ltd.
- Suzhou Fushilai Pharmaceutical Co., Ltd. authorizes a Buyback Plan.